RLMD
Price
$3.21
Change
-$0.09 (-2.73%)
Updated
Nov 13 closing price
131 days until earnings call
SCPX
Price
$0.74
Change
-$0.06 (-7.50%)
Updated
Nov 13 closing price
Ad is loading...

RLMD vs SCPX

Header iconRLMD vs SCPX Comparison
Open Charts RLMD vs SCPXBanner chart's image
Relmada Therapeutics
Price$3.21
Change-$0.09 (-2.73%)
Volume$108.25K
CapitalizationN/A
SCORPIUS HOLDINGS
Price$0.74
Change-$0.06 (-7.50%)
Volume$98.29K
CapitalizationN/A
RLMD vs SCPX Comparison Chart
Loading...
RLMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RLMD vs. SCPX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLMD is a StrongSell and SCPX is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (RLMD: $3.22 vs. SCPX: $0.74)
Brand notoriety: RLMD and SCPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLMD: 51% vs. SCPX: 80%
Market capitalization -- RLMD: $97.16M vs. SCPX: $2.31M
RLMD [@Biotechnology] is valued at $97.16M. SCPX’s [@Biotechnology] market capitalization is $2.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLMD’s FA Score shows that 1 FA rating(s) are green whileSCPX’s FA Score has 1 green FA rating(s).

  • RLMD’s FA Score: 1 green, 4 red.
  • SCPX’s FA Score: 1 green, 4 red.
According to our system of comparison, RLMD is a better buy in the long-term than SCPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLMD’s TA Score shows that 4 TA indicator(s) are bullish.

  • RLMD’s TA Score: 4 bullish, 5 bearish.

Price Growth

RLMD (@Biotechnology) experienced а -5.29% price change this week, while SCPX (@Biotechnology) price change was -8.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

RLMD is expected to report earnings on Mar 25, 2025.

SCPX is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLMD($97.2M) has a higher market cap than SCPX($2.31M). RLMD YTD gains are higher at: -22.222 vs. SCPX (-99.157). SCPX has higher annual earnings (EBITDA): -23.14M vs. RLMD (-91.33M). RLMD has more cash in the bank: 70.4M vs. SCPX (1.51M). RLMD has less debt than SCPX: RLMD (256K) vs SCPX (15.9M). SCPX has higher revenues than RLMD: SCPX (9.85M) vs RLMD (0).
RLMDSCPXRLMD / SCPX
Capitalization97.2M2.31M4,204%
EBITDA-91.33M-23.14M395%
Gain YTD-22.222-99.15722%
P/E RatioN/AN/A-
Revenue09.85M-
Total Cash70.4M1.51M4,672%
Total Debt256K15.9M2%
FUNDAMENTALS RATINGS
RLMD vs SCPX: Fundamental Ratings
RLMD
SCPX
OUTLOOK RATING
1..100
8278
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4865
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCPX's Valuation (7) in the Biotechnology industry is in the same range as RLMD (32) in the null industry. This means that SCPX’s stock grew similarly to RLMD’s over the last 12 months.

SCPX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RLMD (100) in the null industry. This means that SCPX’s stock grew similarly to RLMD’s over the last 12 months.

SCPX's SMR Rating (97) in the Biotechnology industry is in the same range as RLMD (97) in the null industry. This means that SCPX’s stock grew similarly to RLMD’s over the last 12 months.

RLMD's Price Growth Rating (48) in the null industry is in the same range as SCPX (65) in the Biotechnology industry. This means that RLMD’s stock grew similarly to SCPX’s over the last 12 months.

RLMD's P/E Growth Rating (100) in the null industry is in the same range as SCPX (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to SCPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RLMD
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
RLMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSWF3269.8343.81
+1.36%
Constellation Software, Inc.
IPXHY13.040.08
+0.62%
Inpex Corp.
UNRG0.04N/A
N/A
United Energy Corp.
RTMVY15.34-0.36
-2.30%
Rightmove Plc
MAIFF0.24-0.01
-3.28%
Minera Alamos, Inc.

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-2.42%
SYRE - RLMD
36%
Loosely correlated
-7.94%
ENTO - RLMD
36%
Loosely correlated
+1.61%
ALVR - RLMD
35%
Loosely correlated
+4.04%
SCPX - RLMD
34%
Loosely correlated
-7.48%
PRTC - RLMD
31%
Poorly correlated
-4.73%
More

SCPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPX has been loosely correlated with SPRB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPX
1D Price
Change %
SCPX100%
-7.48%
SPRB - SCPX
43%
Loosely correlated
-2.78%
FENC - SCPX
39%
Loosely correlated
+6.15%
VRPX - SCPX
37%
Loosely correlated
N/A
ALVR - SCPX
34%
Loosely correlated
+4.04%
BOLT - SCPX
33%
Loosely correlated
-2.46%
More